DocDollars

Rhythm Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000966832

Total reported 2019–2025
$30.2M
#238 of 2,960 reporting companies — 0% of all reported industry payments
$995K in general payments across 6,014 records, plus $29.2M in research funding across 9,368 records.

How it breaks down

General payments $994,864
Research funding $29,243,373

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Rhythm Pharmaceuticals, Inc. reported $30.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #238 of 2,960 reporting companies. 97% of that was research funding and 3% general payments such as consulting, speaking, food and travel. 6,014 general payment records and 9,368 research records were filed.

Common questions about Rhythm Pharmaceuticals, Inc.

How much has Rhythm Pharmaceuticals, Inc. paid US doctors?

Rhythm Pharmaceuticals, Inc. reported $30,238,237 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $994,864 in general payments, $29,243,373 in research funding.

How does Rhythm Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #238 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Rhythm Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.